ArticleMolecular cancer research : MCR2025

Exploiting YES1-Driven EGFR Expression Improves the Efficacy of EGFR Inhibitors.

Leslie Cuellar-Vite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.